Her Canna Life Q&A Interview with Stephanie Karasick, Founder, Strainprint Technologies Ltd.
February 23, 2018 – Strainprint Founder Stephanie Karasick was featured in Her Canna Life High-Minded Women Q&A
Medical Cannabis & Women’s Health: Exploring the Connection
A strong focus on women’s health has dramatically evolved over the years. New therapeutic approaches are emerging to promote and regulate women’s health, and medical cannabis is leading the way. Strainprint is collecting and disseminating information from tens of thousands patients across the country. More than half of Strainprint users are women, and it’s […]
Strainprint™ Technologies Ltd. Welcomes 48North Cannabis Co. parent company of ACMPR Licensed Producer Delshen Therapeutics
Strainprint™ – the leader in cannabis data collection and strain efficacy reporting – is excited to announce that 48North Cannabis (48North) has subscribed to Strainprint’s world-leading cannabis data & analytics platform to help guide its operational growth and product development.
Terpenes & The Entourage Effect: What’s all the Fuss
If you have a medicinal, recreational or scientific interest in the cannabis plant, the term “terpenes” has most likely popped up as you educate yourself on cannabis and the way it interacts with the human body. The importance of terpenes in all species of plants, especially cannabis, can’t be underestimated. Terpenes are fundamental building blocks […]
Stephanie Karasick Featured in High Canada – Women & Weed
Our Founder, Stephanie Karasick was recently profiled in HIGH Canada’s Women and Weed feature. Here she shares her personal medical cannabis journey, which was the genesis of the Strainprint App. Her full story can be found on page 58 of the December Edition.
Daily Marijuana Observer – Better Know a CTO
Our President and Chief Technology Officer, Dave Berg was recently featured in the The Daily Marijuana Observer – Get to know all about what makes Dave tick, and why he’s so passionate about Strainprint.
National Post – Open Letter To ACMPR Medical Cannabis Patients
National Post – Open Letter To ACMPR Medical Cannabis Patients Strainprint advocates for carving out and preserving our world class Medical Cannabis program. Read our letter posted in the National Post, share, and let Finance Canada know that taxing medical cannabis is wrong! #donttaxmedicine
Blyss Cloud – Why We Love The Strainprint Marijuana App
Recently, the Strainprint App was featured on Blyss Cloud. Read all about why they love the Strainprint App!
5 Unique Facts About Cannabidiol (CBD)
When talking about cannabis, there are two main cannabinoids that make their way into most cannabis discourses: THC and CBD. While each are of equal value amongst the hundreds of cannabinoid compounds within the cannabis plant, they serve very different functions for the user and achieve different effects.